RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Caroline Appleyard to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Caroline Appleyard has written about Protein Kinase Inhibitors.
Caroline Appleyard
Connection Strength
0.384
Protein Kinase Inhibitors
  1. Pag?n B, Isidro AA, Cruz ML, Ren Y, Coppola D, Wu J, Appleyard CB. Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model. World J Gastroenterol. 2011 Nov 28; 17(44):4858-66.
    View in: PubMed
    Score: 0.384
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support